Ver Investigador - - Prisma - Unidad de Bibliometría

Manuel Alejandro Gonzalez-Serna Martin

Investiga en

Tipo Año Título Fuente
Artículo2024 Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Artículo2024 Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain Enfermedades infecciosas y microbiología clínica
Artículo2024 Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV JOURNAL OF INFECTIOUS DISEASES
Artículo2024 The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study) ANTIVIRAL RESEARCH
Artículo2023 A metagenome-wide association study of HIV disease progression in HIV controllers iScience
Artículo2023 Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus. JOURNAL OF INFECTION
Resumen congreso2023 Changes in the prevalence of hepatitis B virus infection in people living with HIV in Seville from 2011 to 2022 HIV MEDICINE
Artículo2023 Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023 Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events EBIOMEDICINE
Artículo2023 Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gain AIDS
Artículo2023 Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide. OPEN FORUM INFECTIOUS DISEASES
Artículo2023 Poor increase on HAV vaccination coverage among people living with HIV after an immunization-based intervention Enfermedades infecciosas y microbiología clínica
Artículo2023 Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2022 Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis Scientific reports
Artículo2022 Discovering HIV related information by means of association rules and machine learning Scientific reports
Artículo2022 High efficacy of Glecaprevir/Pibrentasvir for HCV-Infected individuals with active drug use. JOURNAL OF INFECTION
Artículo2022 Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: a Spanish nationwide cohort HIV MEDICINE
Artículo2021 A genome-wide association study on liver stiffness changes during hepatitis c virus infection cure Diagnostics
Artículo2021 COVID-19 in hospitalized HIV-positive and HIV-negative patients: a matched study HIV MEDICINE
Artículo2021 How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort BMC WOMENS HEALTH
Artículo2021 Impact of recent drug use on the efficacy of Elbasvir/Grazoprevir for HCV-infected people on opioid agonist therapy. JOURNAL OF VIRAL HEPATITIS
Artículo2021 Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain HIV MEDICINE
Resumen congreso2021 Liver disease in people living with HIV (PLWHIV) after the microelimination of HCV infection HIV MEDICINE
Artículo2021 Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Resumen congreso2021 No influence of ART on the response to glecaprevir/pibrentasvir in clinical practice HIV MEDICINE
Resumen congreso2021 Poor increase on HAV vaccination coverage among people living with HIV after an immunization-based intervention HIV MEDICINE
Artículo2021 Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy. PLOS ONE
Resumen congreso2021 Weight gain after switching to integrase inhibitor-based ART is not associated with hepatic steatosis in HIV-infected patients HIV MEDICINE
Artículo2020 Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study AIDS RESEARCH AND THERAPY
Artículo2020 High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment Scientific reports
Artículo2020 Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019 A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study) LIVER INTERNATIONAL
Artículo2017 Genotypic susceptibility score (GSS) and CD4+T cell recovery in HIV-1 patients with suppressed viral load JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017 Increased CD127+and decreased CD57+T cell expression levels in HIV-infected patients on NRTI-sparing regimens JOURNAL OF TRANSLATIONAL MEDICINE
Letter2017 Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Artículo2017 Relationship between CCR5((WT/Delta 32)) heterozygosity and HIV-1 reservoir size in adolescents and young adults with perinatally acquired HIV-1 infection CLINICAL MICROBIOLOGY AND INFECTION
Artículo2016 A single untimed plasma drug concentration measurement during low-level HIV viremia predicts virologic failure CLINICAL MICROBIOLOGY AND INFECTION
Letter2016 Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naive patients DRUG DESIGN DEVELOPMENT AND THERAPY
Artículo2016 Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014 HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure AIDS
Artículo2014 Performance of HIV-1 Drug Resistance Testing at Low-Level Viremia and Its Ability to Predict Future Virologic Outcomes and Viral Evolution in Treatment-Naive Individuals CLINICAL INFECTIOUS DISEASES
Artículo2014 Temporal trends in the discontinuation of first-line antiretroviral therapy JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2013 "Test-and-Treat" Strategy for Control of HIV and AIDS Can Lead to a Decrease, Not an Increase, of Multidrug-Resistant Viruses CLINICAL INFECTIOUS DISEASES
Artículo2013 CD8 TCR beta chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption JOURNAL OF CLINICAL VIROLOGY
Resumen congreso2013 HIV drug resistance occurring during low-level viraemia is associated with subsequent virological failure ANTIVIRAL THERAPY
Artículo2012 Correlation of the Virological Response to Short-Term Maraviroc Monotherapy with Standard and Deep-Sequencing-Based Genotypic Tropism Prediction Methods ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 Different biological significance of sCD14 and LPS in HIV-infection: Importance of the immunovirology stage and association with HIV-disease progression markers JOURNAL OF INFECTION
Artículo2012 Effect of Maraviroc on HIV Disease Progression-Related Biomarkers ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 HIV-1 Tropism Evolution after Short-Term Maraviroc Monotherapy in HIV-1-Infected Patients ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 Patients on a combined antiretroviral therapy after maraviroc clinical test show no immunovirological impairment ANTIVIRAL RESEARCH
Artículo2011 Discordance rates between Trofile (R) test and short-term virological response to maraviroc ANTIVIRAL RESEARCH
Artículo2011 Virological Response after Short-Term CCR5 Antagonist Exposure in HIV-Infected Patients: Frequency of Subjects with Virological Response and Associated Factors ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010 Long-Term Immunovirogical Effect and Tolerability of a Maraviroc-Containing Regimen in Routine Clinical Practice CURRENT HIV RESEARCH
Artículo2010 TROCAI (Tropism Coreceptor Assay Information): a New Phenotypic Tropism Test and Its Correlation with Trofile Enhanced Sensitivity and Genotypic Approaches JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2009 Correlation between the Trofile (R) test and virological response to a short-term maraviroc exposure in HIV-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Resumen congreso2007 Cytogenetic abnormalities in 350 patients diagnosed with B-cell chronic lymphocytic leukemiaand relationship with igvh mutational status HAEMATOLOGICA
Resumen congreso2001 Paclitaxel and rhG-CSF mobilizes a high amount of progenitor cells with a minimun number of apheresis and low toxicity in patients with lymphoma. BLOOD
Análisis de los ensayos de tropismo del VIH-1 TROCAI (2012)
Dirigida por: Ezequiel Ruiz-Mateos Carmona, Manuel Leal Noval

Este investigador no ha dirigido/tutorizado tesis

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/09/2023 31/08/2025 Responsable Modelo predictivo de supervivencia y eventos clínicos basado en el envejecimiento celular para individuos con hepatitis C crónica que logran respuesta viral sostenida (CNS2022-136054) Ministerio de Ciencia e Innovación (Nacional)
El investigador no tiene ningún resultado de investigación asociado